ALSA Ventures

Equity. Early stage biotech.

Information last verified: April 2026

Cheque size

£500k - £10M

Stage

Idea / pre-product, MVP / early product

Region

UK-wide

Type

equity

Sector focus

Health/Life Sciences

Biotechnology investor focused on early-stage opportunities in Europe. Life sciences and biotech specialist.

Visit their website for current investment criteria, portfolio, and how to get in touch.

Something wrong or out of date? Let us know →